Coronary thrombolysis with tissue-type plasminogen activator (t-PA): Emerging strategies
- 30 November 1986
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 8 (5) , 1220-1225
- https://doi.org/10.1016/s0735-1097(86)80404-1
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Prevention of coronary thrombosis with subthrombolytic doses of tissue-type plasminogen activator.Circulation, 1985
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985
- Thrombolytic therapy in patients with acute myocardial infarction.Circulation, 1985
- Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial.Circulation, 1984
- Thrombolysis, clot selectivity, and kinetics.Circulation, 1984
- Coronary Thrombolysis with Tissue-Type Plasminogen Activator in Patients with Evolving Myocardial InfarctionNew England Journal of Medicine, 1984
- Coronary thrombolysis with intravenously administered human tissue-type plasminogen activator produced by recombinant DNA technology.Circulation, 1984
- Systemic thrombolytic therapy of acute myocardial infarction?Circulation, 1983
- The time course and characterization of myocardial hemorrhage after coronary reperfusion in the anesthetized dog.Circulation, 1983
- Factors Influencing Infarct Size Following Experimental Coronary Artery OcclusionsCirculation, 1971